Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
Constanze Schmidt(Goethe University Frankfurt), Dierk Thomas(Heidelberg University), Dobromir Dobrev(University of Duisburg-Essen), Arjang Ruhparwar(Essen University Hospital), Niels Voigt(Universitätsmedizin Göttingen), Martin Borggrefe(University of Padua), Siegfried Lang(Heidelberg University), Jordi Heijman(Medical University of Graz), Hugo A. Katus(Heidelberg University), Stefan M. Kallenberger(Goethe University Frankfurt), Patrick Lugenbiel(Heidelberg University), Birgit Donner(Goethe University Frankfurt), Péter Biliczki(Goethe University Frankfurt), Gábor Szabó(Heidelberg University), Virginia Albert(Goethe University Frankfurt), Felix Wiedmann(Heidelberg University), Patrick A. Schweizer(Goethe University Frankfurt), Klaus Kallenbach(Goethe University Frankfurt), Xiao-Bo Zhou(Goethe University Frankfurt), Joachim R. Ehrlich(Goethe University Frankfurt), Matthias Karck(Heidelberg University), István Baczkó(Goethe University Frankfurt)
Cited by 195
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k